|
Volumn 14, Issue 12, 2000, Pages 627-635
|
Oral lesions in HIV/AIDS patients undergoing highly active antiretroviral treatment including protease inhibitors: A new face of oral AIDS?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIRETROVIRUS AGENT;
CD4 ANTIGEN;
INDINAVIR;
LAMIVUDINE;
PROTEINASE INHIBITOR;
RITONAVIR;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
SAQUINAVIR;
ZIDOVUDINE;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ADULT;
ARTICLE;
BLOOD TRANSFUSION;
FEMALE;
GINGIVITIS;
HERPES LABIALIS;
HETEROSEXUALITY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INTRAVENOUS DRUG ABUSE;
LEUKOPLAKIA;
MAJOR CLINICAL STUDY;
MALE;
MELANOSIS;
MOUTH LESION;
PERIODONTITIS;
PREVALENCE;
THRUSH;
VIRUS LOAD;
XEROSTOMIA;
ADULT;
AGED;
AIDS-RELATED OPPORTUNISTIC INFECTIONS;
ANTI-HIV AGENTS;
ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE;
CANDIDIASIS, ORAL;
CASE-CONTROL STUDIES;
CD4 LYMPHOCYTE COUNT;
FEMALE;
GINGIVITIS;
HERPES LABIALIS;
HIV INFECTIONS;
HIV PROTEASE INHIBITORS;
HUMANS;
INDINAVIR;
LAMIVUDINE;
LEUKOPLAKIA, HAIRY;
MALE;
MIDDLE AGED;
MOUTH DISEASES;
PERIODONTITIS;
PREVALENCE;
VIRAL LOAD;
XEROSTOMIA;
ZIDOVUDINE;
|
EID: 0033675542
PISSN: 10872914
EISSN: None
Source Type: Journal
DOI: 10.1089/10872910050206540 Document Type: Article |
Times cited : (107)
|
References (34)
|